PIPA520796

PALB2 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA520796-Each-of-1 In Stock ₹ 48,994.50

PIPA520796 - Each of 1

₹ 48,994.50

In Stock

Quantity

1

Base Price: ₹ 48,994.50

GST (18%): ₹ 8,819.01

Total Price: ₹ 57,813.51

Antigen

PALB2

Classification

Polyclonal

Conjugate

Unconjugated

Gene

Palb2

Gene Alias

BC066140; FANCN; FLJ21816; PALB2; Partner and localizer of BRCA2; PNCA3; RGD1304759

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

233826, 293452, 79728

Content And Storage

Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C

Form

Liquid

Applications

Western Blot

Concentration

1 mg/mL

Formulation

PBS with 0.02% sodium azide

Gene Accession No.

Q3U0P1, Q86YC2

Gene Symbols

Palb2

Immunogen

A 15 amino acid peptide from near the carboxy terminus of human PALB2.

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Human, Mouse, Rat

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA520734

--

Img

Thermo Scientific

PIPA521164

--

Img

Thermo Scientific

PIPA520993

--

Img

Thermo Scientific

PIPA521083

--

Img

Thermo Scientific

PIPA520984

--

Img

Thermo Scientific

PIPA520854

--

Img

Thermo Scientific

PIPA520819

--

Img

Thermo Scientific

PIPA520931

--

Description

  • A suggested positive control is SK-N-SH cell lysate
  • PA5-20796 can be used with blocking peptide PEP-0910
  • The breast cancer early onset proteins BRCA1 and BRCA2 are central to the repair of DNA damage by homologous recombination and are strongly associated with inherited breast and ovarian cancer
  • The protein PALB2 is required for the localization of BRCA2 to sites of DNA damage and like BRCA1 and 2 is a breast cancer susceptibility gene
  • PALB2 is thought to function through directly binding to BRCA1, which allows the PALB2 protein to organize BRCA2 and the recombinase RAD51 at the site of DNA damage
  • Analysis of the BRCA1-PALB2-BRCA2-RAD51network may allow predictions to be made of the responsiveness of a particular tumor to therapeutic treatments
  • At least four isoforms of PALB2 are known to exist.